Study of Prognostic Factors in Adult Lymphoblastic Lymphoma
Study of Prognostic Factors in Adult Lymphoblastic Lymphoma
Retrospective observational study with systematic collection of data on filiation (age at
 diagnosis and sex), clinical data (IPI, ECOG, early response to chemotherapy, overall
 response to chemotherapy), biological (strain B or T, infiltration of the nervous system
 central [CNS], bone marrow [MO], lactate dehydrogenase (LDH) level at the time of diagnosis,
 as well as genetic patients included in the study, as well as the PETHEMA protocol used in
 the treatment of same patients The study will review the PETHEMA protocols from 2003 to the
 present
Retrospective observational study with systematic collection of data on filiation (age at
 diagnosis and sex), clinical data (IPI, ECOG, early response to chemotherapy, overall
 response to chemotherapy), biological (strain B or T, infiltration of the nervous system
 central [CNS], bone marrow [MO], lactate dehydrogenase (LDH) level at the time of diagnosis,
 as well as genetic patients included in the study, as well as the PETHEMA protocol used in
 the treatment of same patients The study will review the PETHEMA protocols from 2003 to the
 present. Analysis of the main clinical-biological variables as independent risk factors in
 adult patients (> 15 years) diagnosed with ALL
Inclusion Criteria:

 Patients >15 years old diagnosed with ALL and treated with the PETHEMA protocols for ALL

 Exclusion Criteria:

 None